Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel insights into renovascular hypertension and cardio-renal protection by iron restriction.

Literature DB >> 27604341

Novel insights into renovascular hypertension and cardio-renal protection by iron restriction.

Atsushi Tanaka¹, Koichi Node¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Iron

Year: 2016 PMID： 27604341 DOI： 10.1038/hr.2016.121

Source DB: PubMed Journal: Hypertens Res ISSN： 0916-9636 Impact factor: 3.872

Keyword Cloud
References

× No keyword cloud information.

22 in total

1. Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction.

Authors: Makiko Oboshi; Yoshiro Naito; Hisashi Sawada; Toshihiro Iwasaku; Yoshitaka Okuhara; Akiyo Eguchi; Shinichi Hirotani; Toshiaki Mano; Takeshi Tsujino; Tohru Masuyama
Journal: Hypertens Res Date: 2016-07-21 Impact factor: 3.872

2. Prospective study of atherosclerotic disease progression in the renal artery.

Authors: M T Caps; C Perissinotto; R E Zierler; N L Polissar; R O Bergelin; M J Tullis; K Cantwell-Gab; R C Davidson; D E Strandness
Journal: Circulation Date: 1998 Dec 22-29 Impact factor: 29.690

3. Predictors of undiagnosed renal artery stenosis among Japanese patients with risk factors of atherosclerosis.

Authors: Masayuki Tanemoto; Harutaka Saitoh; Fumitoshi Satoh; Hiroshi Satoh; Takaaki Abe; Sadayoshi Ito
Journal: Hypertens Res Date: 2005-03 Impact factor: 3.872

4. Dietary iron restriction prevents hypertensive cardiovascular remodeling in Dahl salt-sensitive rats.

Authors: Yoshiro Naito; Shinichi Hirotani; Hisashi Sawada; Hirokuni Akahori; Takeshi Tsujino; Tohru Masuyama
Journal: Hypertension Date: 2011-01-24 Impact factor: 10.190

5. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

Authors: D S Silverberg; D Wexler; M Blum; G Keren; D Sheps; E Leibovitch; D Brosh; S Laniado; D Schwartz; T Yachnin; I Shapira; D Gavish; R Baruch; B Koifman; C Kaplan; S Steinbruch; A Iaina
Journal: J Am Coll Cardiol Date: 2000-06 Impact factor: 24.094

Novel insights into renovascular hypertension and cardio-renal protection by iron restriction.

1. Attenuation of hypertension and renal damage in renovascular hypertensive rats by iron restriction.

2. Prospective study of atherosclerotic disease progression in the renal artery.

3. Predictors of undiagnosed renal artery stenosis among Japanese patients with risk factors of atherosclerosis.

4. Dietary iron restriction prevents hypertensive cardiovascular remodeling in Dahl salt-sensitive rats.

5. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

6. Correction of anemia with epoetin alfa in chronic kidney disease.

7. Cardiac remodeling in response to chronic iron deficiency: role of the erythropoietin receptor.

8. Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury.

9. Dietary iron restriction prevents further deterioration of renal damage in a chronic kidney disease rat model.

Review 10. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives.